Active Ingredients Market Research Report Information By End Use (Personal care & Cosmetics, Pharmaceuticals, Agrochemicals) By Region (North America, Europe, Asia Pacific) Forecast till 2028

Table of Contents

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global Active IngredientsMarket, by End Use

1.1.2. Global Active IngredientsMarket, by Region

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.3. Market Structure

3. RESEARCH METHODOLOGY

3.1. Research Process

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

3.5. Forecast Model

3.6. List of Assumptions& Assumptions

4. MARKET DYNAMICS

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Trends

5. MARKET FACTOR ANALYSIS

5.1. Supply Chain Analysis

5.1.1. Raw Material Suppliers

5.1.2. Active IngredientsManufacturers

5.1.3. Distribution & Sales Channel

5.1.4. EndUsers

5.2. Porter’s Five Forces Model

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. Pricing Analysis(USD/Tons), by Region

5.4. Impact of COVID-19 on the Global Active IngredientsMarket

6. GLOBAL ACTIVE INGREDIENTS MARKET, BYEND USE (KILOTONS) (USD MILLION)

6.1. Introduction

6.2. Personal Care & Cosmetics

6.2.1. Market Estimates & Forecast, by Region/Country, 2019–2028

6.3. Pharmaceuticals

6.3.1. Market Estimates & Forecast, by Region/Country, 2019–2028

6.4. Agrochemicals

6.4.1. Market Estimates & Forecast, by Region/Country, 2019–2028

7. GLOBAL ACTIVE INGREDIENTS MARKET, BYREGION(KILOTONS) (USD MILLION)

7.1. Overview

7.2. North America

7.2.1. US

7.2.2. Canada

7.3. Europe

7.3.1. Germany

7.3.2. UK

7.3.3. France

7.3.4. Russia

7.3.5. Spain

7.3.6. Denmark

7.3.7. Italy

7.3.8. Rest of Europe

7.4. Asia-Pacific

7.4.1. China

7.4.2. Japan

7.4.3. India

7.4.4. South Korea

7.4.5. Australia & New Zealand

7.4.6. Indonesia

7.4.7. Rest of Asia-Pacific

7.5. Latin America

7.5.1. Brazil

7.5.2. Mexico

7.5.3. Argentina

7.5.4. Rest of Latin America

7.6. Middle East & Africa

7.6.1. Turkey

7.6.2. UAE

7.6.3. Saudi Arabia

7.6.4. South Africa

7.6.5. Rest of the Middle East & Africa

8. COMPETITIVE LANDSCAPE

8.1. Market Introduction

8.2. Recent Developments

8.2.1. Mergers/Acquisitions, Expansion, Investment, Partnership, Collaboration, Product Launch

8.3. Global Market Strategy Analysis

8.4. Competitive Benchmarking

9. COMPANY PROFILES

9.1. AkzoNobel N.V.

9.1.1. Company Overview

9.1.2. Financial Overview

9.1.3. Products Offered

9.1.4. Key Developments

9.1.5. SWOT Analysis

9.1.6. Key Strategies

9.2. Ashland

9.2.1. Company Overview

9.2.2. Financial Overview

9.2.3. Products Offered

9.2.4. Key Developments

9.2.5. SWOT Analysis

9.2.6. Key Strategies

9.3. BASF SE

9.3.1. Company Overview

9.3.2. Financial Overview

9.3.3. Products Offered

9.3.4. Key Developments

9.3.5. SWOT Analysis

9.3.6. Key Strategies

9.4. Clariant

9.4.1. Company Overview

9.4.2. Financial Overview

9.4.3. Products Offered

9.4.4. Key Developments

9.4.5. SWOT Analysis

9.4.6. Key Strategies

9.5. Evonik Industries AG

9.5.1. Company Overview

9.5.2. Financial Overview

9.5.3. Products Offered

9.5.4. Key Developments

9.5.5. SWOT Analysis

9.5.6. Key Strategies

9.6. Lonza

9.6.1. Company Overview

9.6.2. Financial Overview

9.6.3. Products Offered

9.6.4. Key Developments

9.6.5. SWOT Analysis

9.6.6. Key Strategies

9.7. Gattefossé

9.7.1. Company Overview

9.7.2. Financial Overview

9.7.3. Products Offered

9.7.4. Key Developments

9.7.5. SWOT Analysis

9.7.6. Key Strategies

9.8. Sumitomo Corporation

9.8.1. Company Overview

9.8.2. Financial Overview

9.8.3. Products Offered

9.8.4. Key Developments

9.8.5. SWOT Analysis

9.8.6. Key Strategies

9.9. DuPont

9.9.1. Company Overview

9.9.2. Financial Overview

9.9.3. Products Offered

9.9.4. Key Developments

9.9.5. SWOT Analysis

9.9.6. Key Strategies

9.10. Croda International Plc

9.10.1. Company Overview

9.10.2. Financial Overview

9.10.3. Products Offered

9.10.4. Key Developments

9.10.5. SWOT Analysis

9.10.6. Key Strategies

9.11. Eastman Chemical Company

9.11.1. Company Overview

9.11.2. Financial Overview

9.11.3. Products Offered

9.11.4. Key Developments

9.11.5. SWOT Analysis

9.11.6. Key Strategies

9.12. FMC Corporation

9.12.1. Company Overview

9.12.2. Financial Overview

9.12.3. Products Offered

9.12.4. Key Developments

9.12.5. SWOT Analysis

9.12.6. Key Strategies

9.13. Sipcam

9.13.1. Company Overview

9.13.2. Financial Overview

9.13.3. Products Offered

9.13.4. Key Developments

9.13.5. SWOT Analysis

9.13.6. Key Strategies

9.14. United Phosphorus Limited

9.14.1. Company Overview

9.14.2. Financial Overview

9.14.3. Products Offered

9.14.4. Key Developments

9.14.5. SWOT Analysis

9.14.6. Key Strategies

9.15. Nufarm Limited

9.15.1. Company Overview

9.15.2. Financial Overview

9.15.3. Products Offered

9.15.4. Key Developments

9.15.5. SWOT Analysis

9.15.6. Key Strategies

9.16. Other Companies

9.16.1. ADAMA Agricultural Solutions Limited

9.16.2. PotashCorp

9.16.3. Israel Chemicals Ltd

9.16.4. K+S AG

9.16.5. IFFCO

9.16.6. Pfizer Inc.

9.16.7. Novartis International AG

9.16.8. Merck & Co.

9.16.9. Teva Pharmaceutical Industries Ltd

9.16.10. Mylan N.V.

9.16.11. Boehringer Ingelheim

9.16.12. F. Hoffmann-La Roche AG

9.16.13. Sanofi

9.16.14. AbbVie

9.16.15. AstraZeneca

10. APPENDIX

10.1.1. Discussion Blueprint